Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

The histone methyltransferase EZH2, a key epigenetic modifier, is known to be associated with human tumorigenesis. However, the physiological importance of EZH2 and its clinical relevance in endometrial cancer remain unclear. Hence, in the present study, we investigated the expression and function o...

Descripción completa

Detalles Bibliográficos
Autores principales: Oki, Shinya, Sone, Kenbun, Oda, Katsutoshi, Hamamoto, Ryuji, Ikemura, Masako, Maeda, Daichi, Takeuchi, Makoto, Tanikawa, Michihiro, Mori-Uchino, Mayuyo, Nagasaka, Kazunori, Miyasaka, Aki, Kashiyama, Tomoko, Ikeda, Yuji, Arimoto, Takahide, Kuramoto, Hiroyuki, Wada-Hiraike, Osamu, Kawana, Kei, Fukayama, Masashi, Osuga, Yutaka, Fujii, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522273/
https://www.ncbi.nlm.nih.gov/pubmed/28418882
http://dx.doi.org/10.18632/oncotarget.16316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522273/
https://www.ncbi.nlm.nih.gov/pubmed/28418882
http://dx.doi.org/10.18632/oncotarget.16316

Ejemplares similares